Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer

Hybridization of non-sulfonylurea insulin secretagogue and thiazolidinedione-derived insulin sensitizer Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents Novel Euglycemic and Hypolipidemic Agents. 1 Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones Insulin-releasing activity of a series of phenylalanine derivatives Molecular Design, Synthesis, and Hypoglycemic Activity of a Series of Thiazolidine-2,4-diones Synthesis and insulin-sensitizing activity of a novel kind of benzopyran derivative Novel sulfonyl(thio)urea derivatives act efficiently both as insulin secretagogues and as insulinomimetic compounds Novel 5-Substituted 2,4-Thiazolidinedione and 2,4-Oxazolidinedione Derivatives as Insulin Sensitizers with Antidiabetic Activities [[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents